With more than 30 years of leadership across the biopharmaceutical industry, Jeff was CSL’s Executive Vice President and GM Asia Pacific, heading its businesses across the region, including China where substantial market expansion was realised. Jeff also had oversight of influenza vaccines, anti-venoms, in licensed vaccines and pharmaceuticals as well as the diagnostic product business. From 2000 to 2005 he was Global Head of Research and Development at CSL and key member of the due diligence team that resulted in CSL’s decision to become a global company (now CSL-Behring).A director of CBE, Jeff advises listed companies, private equity and major institutions on investments, strategy, R&D portfolios, organisational design, regulatory matters, product development and clinical strategies and audits. He has advised on areas including plasma products, vaccines, stem cell development programs, diagnostic product development and protein purification.Jeff has held a number of senior advisory roles, including sitting on the Pharmaceutical Industry Council, the Australian Red Cross Advisory Board and Medicines Australia.